Health charities sue FDA over extended deeming deadlines

Public health groups have brought a suit against the US Food and Drug Administration (FDA) for extending deadlines for e-cigs and cigars on its controversial deeming regulations.

They argue that these extensions keep flavours on the market, attracting young people to the products and encouraging youth uptake.

The suit was brought by a who’s who of tobacco control organisations, including the Campaign for Tobacco-Free Kids, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Truth Initiative, and American Academy of Pediatrics.

They claim the FDA has offered “no meaningful justification for ripping a hole in the statutory framework by exempting, for more than half a decade, newly deemed products from premarket review – review FDA previously described as ‘central’ to the regulatory scheme Congress enacted for tobacco products.”

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ Health charities sue FDA over extended deeming deadlines ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Health charities sue FDA over extended deeming deadlines ”






      Public health groups have brought a suit against the US Food and Drug Administration (FDA) for extending deadlines for e-cigs and cigars on its controversial deeming regulations.

      They argue that these extensions keep flavours on the market, attracting young people to the products and encouraging youth uptake.

      The suit was brought by a who’s who of tobacco control organisations, including the Campaign for Tobacco-Free Kids, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Truth Initiative, and American Academy of Pediatrics.

      They claim the FDA has offered “no meaningful justification for ripping a hole in the statutory framework by exempting, for more than half a decade, newly deemed products from premarket review – review FDA previously described as ‘central’ to the regulatory scheme Congress enacted for tobacco products.”

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik